139.80
price down icon0.17%   -0.2089
 
loading
Aptargroup Inc. stock is currently priced at $139.80, with a 24-hour trading volume of 123.02K. It has seen a -0.17% decreased in the last 24 hours and a -2.23% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $140.2 pivot point. If it approaches the $139.5 support level, significant changes may occur.
Previous Close:
$140.01
Open:
$139.84
24h Volume:
123.02K
Market Cap:
$9.24B
Revenue:
$3.49B
Net Income/Loss:
$284.49M
P/E Ratio:
33.21
EPS:
4.21
Net Cash Flow:
$256.84M
1W Performance:
+0.48%
1M Performance:
-2.23%
6M Performance:
+14.22%
1Y Performance:
+18.38%
1D Range:
Value
$138.92
$140.38
52W Range:
Value
$111.62
$145.35

Aptargroup Inc. Stock (ATR) Company Profile

Name
Name
Aptargroup Inc.
Name
Phone
815-477-0424
Name
Address
475 West Terra Cotta Avenue, Suite E, Crystal Lake, IL
Name
Employee
13,200
Name
Twitter
@aptar
Name
Next Earnings Date
2024-05-01
Name
Latest SEC Filings
Name
ATR's Discussions on Twitter

Aptargroup Inc. Stock (ATR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-03-24 Upgrade Robert W. Baird Neutral → Outperform
Aug-02-21 Downgrade William Blair Outperform → Mkt Perform
Apr-14-21 Downgrade Robert W. Baird Outperform → Neutral
Oct-14-20 Initiated Seaport Global Securities Neutral
Apr-27-20 Upgrade BofA/Merrill Neutral → Buy
Mar-25-20 Upgrade BMO Capital Markets Market Perform → Outperform
Mar-04-20 Upgrade Wells Fargo Equal Weight → Overweight
Feb-26-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-08-19 Initiated Morgan Stanley Overweight
Apr-05-19 Reiterated BofA/Merrill Underperform
Feb-27-19 Upgrade Robert W. Baird Neutral → Outperform
May-18-18 Initiated Jefferies Hold
Dec-07-16 Downgrade BofA/Merrill Buy → Underperform
Oct-13-16 Initiated Jefferies Hold
Jan-05-16 Downgrade Robert W. Baird Outperform → Neutral
Nov-02-15 Upgrade Deutsche Bank Hold → Buy
Sep-15-15 Upgrade BofA/Merrill Neutral → Buy
May-01-15 Upgrade BofA/Merrill Underperform → Neutral
Feb-19-13 Reiterated Deutsche Bank Hold
Jan-08-13 Upgrade Robert W. Baird Neutral → Outperform
Jul-10-12 Downgrade KeyBanc Capital Mkts Buy → Hold
Apr-11-12 Initiated KeyBanc Capital Mkts Buy
Jun-13-11 Upgrade KeyBanc Capital Mkts Hold → Buy
View All

Aptargroup Inc. Stock (ATR) Financials Data

Aptargroup Inc. (ATR) Revenue 2024

ATR reported a revenue (TTM) of $3.49 billion for the quarter ending December 31, 2023, a +4.97% rise year-over-year.
loading

Aptargroup Inc. (ATR) Net Income 2024

ATR net income (TTM) was $284.49 million for the quarter ending December 31, 2023, a +18.89% increase year-over-year.
loading

Aptargroup Inc. (ATR) Cash Flow 2024

ATR recorded a free cash flow (TTM) of $256.84 million for the quarter ending December 31, 2023, a +57.57% increase year-over-year.
loading

Aptargroup Inc. (ATR) Earnings per Share 2024

ATR earnings per share (TTM) was $4.25 for the quarter ending December 31, 2023, a +18.72% growth year-over-year.
loading

Aptargroup Inc. Stock (ATR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Kampouri Monnas Giovanna
Director
Mar 12 '24
Sale
142.45
2,000
284,906
9,648
Touya Gael
Segment President
Mar 11 '24
Sale
142.84
3,500
499,932
33,426
Tanda Stephan B.
President and CEO
Mar 04 '24
Option Exercise
74.79
32,000
2,393,280
191,024
Tanda Stephan B.
President and CEO
Mar 04 '24
Sale
141.67
32,000
4,533,394
159,024
Prieur Marc
Segment President
Dec 07 '23
Sale
126.24
3,200
403,968
13,828
Kampouri Monnas Giovanna
Director
Nov 24 '23
Sale
128.38
2,387
306,447
11,648
FOTIADES GEORGE L
Director
Aug 28 '23
Option Exercise
66.59
9,500
632,605
14,462
FOTIADES GEORGE L
Director
Aug 28 '23
Sale
128.46
9,500
1,220,333
4,962
Tlili Hedi
Segment President
Aug 24 '23
Sale
125.23
2,989
374,304
9,379
FOTIADES GEORGE L
Director
Aug 10 '23
Sale
122.01
7,940
968,760
4,962
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates in three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and household markets; and pumps and decorative components to the beauty market. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market. The Food + Beverage segment offers dispensing and non-dispensing closures, spray pumps, and aerosol valves to the food and beverage markets. The company also manufactures and sells elastomeric primary packaging components for injectable market, which include stoppers for infusion, antibiotic, lyophilization, and diagnostic vials; and pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, and dropper bulbs and syringe plungers. AptarGroup, Inc. sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company was founded in 1992 and is headquartered in Crystal Lake, Illinois.
medical_instruments_supplies TFX
$206.46
price down icon 2.36%
medical_instruments_supplies COO
$89.21
price down icon 1.04%
$75.75
price down icon 1.25%
medical_instruments_supplies BAX
$39.88
price down icon 2.64%
medical_instruments_supplies RMD
$180.82
price down icon 1.59%
Cap:     |  Volume (24h):